Tech Company Financing Transactions
Theranica Funding Round
Theranica, based in Montclair, secured $45 million from New Rhein Healthcare Investors, aMoon Partners and Lightspeed Venture Partners.
Transaction Overview
Company Name
Announced On
8/29/2022
Transaction Type
Venture Equity
Amount
$45,000,000
Round
Series C
Investors
Proceeds Purpose
The company, which has extended the financing round, planning a final closing in October, intends to use the funds to expand its commercial activity in the U.S.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
151 Forest St. Unit D
Montclair, NJ 07042
USA
Montclair, NJ 07042
USA
Phone
Website
Email Address
Overview
We are a highly experienced ambitious team that has set a goal to translate our technological and business knowledge in mobile digital solutions to the field of pain therapeutics. We offer non-invasive, drug-free, personalized and affordable wearable therapeutic products for the treatment of pain by integrating the latest neuroscience research with notable technological expertise.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alon Ironi
Chief Financial Officer
Eran Porat
Chief Operating Officer
Ronen Jashek
Chief Scientific Officer
Liron Rabany
President
Scott Szymanski
Vice President
Alit Stark-Inbar
VP - R & D
Slava Barabash
VP - Regulatory Affairs
Dagan Harris
Browse more venture capital transactions:
Prev: 8/29/2022: Qbtech venture capital transaction
Next: 8/29/2022: Anuva venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. All VC database entries reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs